Diagnosis and Therapy of Organ Dysfunction Using Sphinganine-1-phosphate

The invention relates to the treatment and diagnosis of organ dysfunction caused by ischemia reperfusion injury. In particular, the invention relates to sphinganine-1-phosphate, a sphingolipid metabolite, and its use in the diagnosing, preventing, and/or treating ischemia reperfusion-associated disorders, including, without limitation, disorders of the kidney, liver, lung, brain, and heart.

Attached files:


Patents:
WO 2,010,077,741

Inventor(s): LEE THOMAS H [US]; KIM MIHWA [US]

Type of Offer: Licensing



« More Diagnostic Patents

---